Research News From August 10, 2016
advertisement
- Islet transplantation provides superior glycemic control with less hypoglycemia compared to continuous subcutaneous insulin infusion (CSII) or multiple daily insulin injections (MDI).
- Well, I Wouldn’t be Any Worse Off, Would I, Than I am Now? A Qualitative Study of Decision-Making, Hopes, and Realities of Adults With Type 1 Diabetes Undergoing Islet Cell Transplantation.
- Duration of Action of Two Insulin Glargine Products, LY2963016 Insulin Glargine and Lantus® Insulin Glargine, in Subjects with Type 1 Diabetes Mellitus.
- Lipid Changes During Basal Insulin Peglispro, Insulin Glargine, or NPH Treatment in 6 IMAGINE Trials.
- Is there a role for gut microbiota in type 1 diabetes pathogenesis?
